NCT07035067View on ClinicalTrials.gov

Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada

Enrolling by invitationOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
Ovarian CancerCaregiver BurdenPatient Burden
Interventions
OTHER

No intervention

No specific intervention is assess in this study.

Trial Locations (1)

H2Y 1V3

PROxy Network, an initiative of PeriPharm Inc., Montreal

Sponsors

Lead Sponsor

PeriPharm
All Listed Sponsors
lead

PeriPharm

OTHER

NCT07035067 - Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada | Biotech Hunter | Biotech Hunter